Drug Trial Radar · NCT00761358
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
Last checked: Nov 19, 2026Latest source record: Nov 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
820
Planned (sponsor's estimate)
Start
Sep 2008
Primary completion
Jun 2010
Study completion Aug 2010
Sponsor
- Lead sponsor
- Zeria PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Sep 29, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to verify the superior efficacy of Z-338 to placebo in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms.
Conditions
- Functional Dyspepsia
Interventions
Z-338Drug
Oral
PlaceboDrug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- General impression at last visit in treatment periodTime frame: 4 week
- Elimination rate of post-prandial fullness, upper abdominal bloating and early satiety at last visit in treatment periodTime frame: 4 week
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Hokkaido, Japan
Site not named
Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.